Federal Register of Legislation - Australian Government

Primary content

PB 64 of 2012 Arrangements as made
This instrument amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (No. PB 116 of 2010) to add 6 pharmaceutical benefits and remove 3 pharmaceutical benefits.
Administered by: Health
Registered 29 Aug 2012
Tabling HistoryDate
Tabled HR10-Sep-2012
Tabled Senate10-Sep-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

PB 64 of 2012

National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No. 7)

 

National Health Act 1953

___________________________________________________________________________

 

 

I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.

Dated     23 August 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

FELICITY MCNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________________

 

 

 

 


1              Name of Instrument

 

(1)                This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No.7).

 

(2)                This Instrument may also be cited as PB 64 of 2012.

 

2             Commencement

This Instrument commences on 1 September 2012.

3              Amendments to PB 116 of 2010

Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).

 

 


Schedule 1                   Amendments

[1]    Schedule 1, entry for Cyclosporin in the form Capsule 25 mg with manner of administration Oral and brand Cicloral

Substitute:

 

Capsule 25 mg

Oral

Cyclosporin Sandoz

SZ

EMP

C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332

 

120

5

C

 

[2]    Schedule 1, entry for Cyclosporin in the form Capsule 50 mg with manner of administration Oral and brand Cicloral

Substitute:

 

Capsule 50 mg

Oral

Cyclosporin Sandoz

SZ

EMP

C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332

 

120

5

C

[3]    Schedule 1, entry for Cyclosporin in the form Capsule 100 mg with manner of administration Oral and brand Cicloral

Substitute:

 

Capsule 100 mg

Oral

Cyclosporin Sandoz

SZ

EMP

C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332

 

120

5

C

[4]    Schedule 1, after entry for Lamivudine in the form of Tablet 100 mg with manner of administration Oral and brand Zeffix

insert:

 

 

 

Zetlam

AF

EMP

C3959 C3960 C3961 C3962

 

56

5

D

 

[5]    Schedule 1, after entry for Lamivudine in the form of Tablet 150 mg with manner of administration Oral and brand Lamivudine RBX

insert:

 

 

 

Alphapharm Lamivudine

AF

EMP

C3586 C3587 C3588 C3589

 

120

5

D

 

[6]    Schedule 1, after entry for Lamivudine in the form of Tablet 300 mg with manner of administration Oral and brand Lamivudine RBX

insert:

 

 

 

Alphapharm Lamivudine

AF

EMP

C3586 C3587 C3588 C3589

 

60

5

D

 

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.